Page 111 - MBCA_FULL REPORT_FINAL_FOR_WEB

107. Ernst, M.F., et al., Trends in the prognosis of patients with primary metastatic breast cancer diagnosed
between 1975 and 2002. Breast, 2007. 16(4): p. 344-51.
108. Andre, F., et al., Breast cancer with synchronous metastases: trends in survival during a 14-year period. J
Clin Oncol, 2004. 22(16): p. 3302-8.
109. Pal, S.K., et al., Impact of modern chemotherapy on the survival of women presenting with de novo
metastatic breast cancer. BMC Cancer, 2012. 12: p. 435.
110. Tevaarwerk, A.J., et al., Survival in patients with metastatic recurrent breast cancer after adjuvant
chemotherapy: little evidence of improvement over the past 30 years. Cancer, 2013. 119(6): p. 1140-8.
111. Pfizer, Breast Cancer Survey. 2014: ASCO Meeting.

112. O’Shaughnessy, J., Extending survival with chemotherapy in metastatic breast cancer. Oncologist, 2005.
10 Suppl 3: p. 20-9.
113. Neal, C., Cancer Stigma and Silence Around the World. 2007.
114. Else-Quest, N.M., et al., Perceived stigma, self-blame, and adjustment among lung, breast and prostate
cancer patients. Psychol Health, 2009. 24 (8): 949-64.
115. Holland, J.C., et al., The human side of cancer: living with hope, coping with uncertainty. Oncology, 2001.
15:8.
116. HINTS Health Information National Trends Survey: HINTS 4, Cycle 3 (2013) demographics.
http://hints.cancer.gov/topic.aspx?section=Demographics. Accessed September 29, 2014.

111